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Abstract
Mammalian sterile 20-like kinase 1 (Mst1) is a critical component of the Hippo signaling pathway, which regulates a variety
of biological processes ranging from cell contact inhibition, organ size control, apoptosis and tumor suppression in
mammals. Mst1 plays essential roles in the heart disease since its activation causes cardiomyocyte apoptosis and dilated
cardiomyopathy. However, the mechanism underlying Mst1 activation in the heart remains unknown. In a yeast two-hybrid
screen of a human heart cDNA library with Mst1 as bait, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
identified as an Mst1-interacting protein. The interaction of GAPDH with Mst1 was confirmed by co-immunoprecipitation in
both co-transfected HEK293 cells and mouse heart homogenates, in which GAPDH interacted with the kinase domain of
Mst1, whereas the C-terminal catalytic domain of GAPDH mediated its interaction with Mst1. Moreover, interaction of Mst1
with GAPDH caused a robust phosphorylation of GAPDH and markedly increased the Mst1 activity in cells. Chelerythrine, a
potent inducer of apoptosis, substantially increased the nuclear translocation and interaction of GAPDH and Mst1 in
cardiomyocytes. Overexpression of GAPDH significantly augmented the Mst1 mediated apoptosis, whereas knockdown of
GAPDH markedly attenuated the Mst1 activation and cardiomyocyte apoptosis in response to either chelerythrine or
hypoxia/reoxygenation. These findings reveal a novel function of GAPDH in Mst1 activation and cardiomyocyte apoptosis
and suggest that disruption of GAPDH interaction with Mst1 may prevent apoptosis related heart diseases such as heart
failure and ischemic heart disease.
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Introduction
Mammalian sterile 20—like kinase 1 (Mst1) is an ubiquitously
expressed serine/threonine kinase with a similarity to the Hippo
kinase from Drosophila and it is a critical component of the Hippo
signaling pathway, which regulates a variety of biological processes
ranging from cell contact inhibition, cell growth, organ size
control, apoptosis and tumor suppression in mammals [1,2].
Human Mst1 has two caspase cleavage sites located between the
catalytic and regulatory domains, which mediate the cleavage of
the autoinhibitory domain [3,4]. Intact Mst1 is localized
predominantly in the cytoplasm, however, in response to a variety
of apoptotic stimuli, Mst1 is cleaved by caspases to produce a 34–
36-kDa N-terminal constitutively active fragment and this cleavage
markedly increases Mst1 kinase activity and translocates the
cleaved Mst1 to the nucleus where it phosphorylates histone H2B
on Ser14, resulting in chromatin condensation, DNA fragmenta-
tion, and, ultimately, cell apoptosis [4–6]. In addition to Histone
H2B, several Mst1 substrates, including FOXO [7–9], LATS1/2
[10,11], JNK [12] and cardiac troponin I [13], have been recently
identified. For instance, MST1 has been shown to phosphorylate
FOXO and promote FOXO nuclear translocation, thereby
inducing apoptosis in neuronal cells [7,8].
Regulation of Mst1 appears to occur mainly at posttranslational
levels. In addition to its activation by proteolytic cleavage, Mst1
autophosphorylation has been proposed to contribute to the kinase
activation [14]. Several phosphorylation sites have been identified
in Mst1, namely Thr175, Thr177, Thr183, Thr187, Ser327 and
Thr387, of which, Thr183 and Thr187 appear to be essential for
kinase activation [14–16]. In addition, protein-protein interactions
have also been shown to play critical roles in the regulation of
Mst1 activity. Thus far, several proteins including Ras association
domain family protein (Rassf) [16–18], hWW45 [17,19], PHLPP1
[20], and Heat Shock Protein 70 (Hsp70) [21], have been
identified to interact with Mst1 and regulate Mst1 activation. For
instance, RASSF family of tumor suppressors have been shown to
interact with and stabilize Mst1, thereby preventing Mst1 for the
degradation and inhibiting tumor growth [18,22]. In contrast, our
recent results demonstrated that Hsp70 decreases Mst1 activity
through promoting Mst1 degradation via a CHIP dependent
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pathway, thereby preventing cancer cells from cisplatin induced
apoptosis [21].
Recently, the physiological role of Mst1 in the cardiovascular
system has begun to be explored. In cardiomyocytes, Mst1 is
activated by pathological stimuli, such as hypoxia/reoxygenation
in vitro and ischemia/reperfusion in vivo [23]. Cardiac-specific
over-expression of Mst1 has been shown to cause dilated
cardiomyopathy in mice [23]. Inhibition of endogenous Mst1
prevents apoptosis of cardiomyocytes and cardiac dysfunction after
myocardial infarction without producing cardiac hypertrophy
[23,24]. Recently, we identified Mst1 as a novel kinase that
mediates cTnI phosphorylation and plays a critical role in the
modulation of myofilament function in the heart [13]. However,
despite these important functions, little is relatively known about
the mechanisms underlying the regulation of the Mst1 activation
in the heart. In an attempt to identify novel cardiac proteins that
may associate with Mst1 and regulate Mst1 activation in the heart,
we performed yeast two-hybrid screen of a human heart cDNA
library using the dominant negative form of Mst1 (K59R) as bait
and subsequently, we identify glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) as a novel Mst1-interacting protein that




HEK293T and Ad293 cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) (Invitrogen) supplemented
with 10% Fetal Bovine Serum (FBS) (Gibco) and were maintained
at 37uC with 5% CO2. Cells were transiently transfected with
FuGENE 6 (Roche Applied Science) using the manufacturer’s
protocol.
Yeast Two-Hybrid library screening and interaction
assays
To identify novel proteins that interact with Mst1, we screened
a human heart cDNA library using human dominant-negative
Mst1 (K59R) as bait and the MATCHMAKER GAL4 yeast 2-
hybrid system 3 (Clontech Laboratories Inc) as previously
described [13,21]. The screening was performed in AH109 yeast
cells according to the protocol provided by the Clontech
Matchmaker Two-Hybrid System. Positive colonies were subject
to multiple rounds of additional selection in the appropriate
medium and b-galactosidase (b-gal) filter assays to verify specific-
ity.
Figure 1. Physical interaction between Mst1 and GAPDH by immunoprecipitation analysis. A, Myc-Mst1 expression vector in
combination of either empty vector or pFlag-GAPDH were co-transfected into HEK293 cells. Extracted proteins were precipitated by anti-FLAG
antibody and then separated by 12% SDS-PAGE. The transferred membrane was immunoblotted with either HRP conjugated anti-Myc or HRP
conjugated anti-FLAG antibody. B, Flag-GAPDH expression vector in combination of either empty vector, pMT2-Myc-Mst1 were co-transfected into
HEK293 cells. Extracted proteins were precipitated by anti-Myc antibody and then separated by 12% SDS-PAGE. The transferred membrane was
immunoblotted with either HRP conjugated anti-Myc or HRP conjugated anti-FLAG antibody. C, HEK293 cells were transfected with Flag-Mst1. 48 hr
after transfection, cells were then treated with etoposide (100 M) or TNF- (20 ng/ml) for 6 hrs. Extracted proteins were precipitated by anti-Flag
antibody and then separated by 12% SDS-PAGE. The transferred membrane was immunoblotted with either anti-Mst1 or anti-Flag antibodies.
doi:10.1371/journal.pone.0058697.g001
Functional Interaction of GAPDH with Mst1
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Primary culture of neonatal rat ventricular myocytes
(NRVMs) and hypoxia/reoxygenation injury
We obtained ventricles from 1-day-old Sprague-Dawley rats
and isolated cardiac myocytes by digestion with trypsin-EDTA
and type 2 collagenase as previously described [25]. Neonatal rats
were obtained from Charles River Laboratories North Wilming-
ton, Mass. This study was reviewed and approved by the
Institutional Animal Care and Use Committee at Thomas
Jefferson University. Hypoxia was achieved by placing the cells
in a hypoxia chamber filled with 5% CO2 and 95% N2 at 37uC for
12 hours. Following hypoxia exposure, cells were reoxygenated by
placing cells in the normoxic culture medium for 24 hours 26]
Coimmunoprecipitation of Mst1 and GAPDH in HEK293T
cells and cardiomyocytes
HEK293T cells were transiently transfected with Mst1 and
GAPDH cDNAs using FuGENE 6 as described by the manufac-
turer (Roche Applied Science). Both HEK293T cells and
cardiomyocytes were lysed in the buffer containing 1% Nonidet
P-40, 150 mmol/L NaCl, 50 mmol/L Tris (pH 8), 100 mmol/L
EDTA, and protease inhibitors. Coimmunoprecipitation of Mst1
and GAPDH was performed essentially as described [25]. The
following antibodies were used for detection and immunoprecip-
itation: rabbit polyclonal c-Myc (Invitrogen), mouse monoclonal
FLAG M2 (Sigma), mouse monoclonal GAPDH (Abcam), rabbit
polyclonal GAPDH (Abcam), anti-Mst1 monoclonal antibody (BD
Transduction Laboratories) and rabbit polyclonal Mst1 (Abgent).
Secondary antibodies were peroxidase-conjugated donkey anti-
rabbit or anti-mouse (Jackson ImmunoResearch). Detection of the
peroxidase was performed with ECL reagents.
Immunofluorescence staining
Freshly isolated neonatal rat cardiomyocytes were fixed and
sequentially incubated with primary antibodies and appropriate
fluorescent-labeled secondary antibodies. Images were visualized
using an Olympus IX70 epifluorescence microscope as previously
described [25].
In Vitro GAPDH phosphorylation assay
To phosphorylate GAPDH in vitro, recombinant GAPDH
(Abcam) was incubated with recombinant active Mst1 (Upstate)
and [c-32P]-ATP (PerkinElmer) in 16kinase assay buffer (40 mM
HEPES-NaOH pH 7.4, 20 mM MgCl2, 1 mM DTT, 1 mM
ATP, 1 mM Na3VO4, 50 mM NaF, and complete protease
inhibitor (Roche) at 30 uC for indicated time points. The reaction
was terminated by adding 1/2 volumes of 36 Laemmli sample
buffer and incubated at 95 uC for 5 min, then examined by 15%
SDS-PAGE and a autoradiography.
Mst1 activity assay
Recombinant active Mst1 (Upstate) or immunoprecipitated
Mst1 from HEK293T transfected with Myc-Mst1 cDNA in
combination with either empty vector or Flag-GAPDH was
incubated for 20 min at 30uC with 4 mg Myelin basic protein
(MBP) (Upstate) in 25 mL kinase buffer 40 mmol/L HEPES-
NaOH (pH 7.4), 20 mmol/L MgCl2, 1 mmol/L DTT, and 1 mCi
[c-32P]-ATP. Reactions were terminated by the addition of 26
SDS sample buffer, and then loaded to 15% SDS-PAGE and
subjected to autoradiography. For Mst1 kinase assay in cardio-
myocytes, cell homogenates (400 mg) were immunoprecipitated
using anti-Mst1 antibody (BD Transduction Laboratories), and
then incubated with 2 mg Histone H2B (Sigma) in 25 mL kinase
assay buffer for 20 min at 30uC. Samples were subjected to SDS-
PAGE and phosphorylation of histone H2B was detected by
immunoblotting with anti-phospho-Histone H2B (Ser14) antibody
(Millipore).
Small interfering RNA of GAPDH
Predesigned GAPDH siRNA and control siRNA were pur-
chased from Ambion. Cardiomyocytes were transfected with
LipofectamineTM RNAiMAX Transfection Reagent (Invitrogen)
with target-specific siRNA (20 nmol/L) and control siRNA
(20 nmol/L) in serum-free medium according to the recommen-
dations of the manufacturer.
Construction of adenoviruses
Adenoviruses harboring wild-type Mst1 (Ad-Mst1), dominant-
negative Mst1 (Ad-DNMST), and GAPDH were made using
AdMax (Microbix) as previously described [21]. Briefly, pBHGlox-
DE1,3XCre, including the DE1 adenoviral genome, was cotrans-
fected with the pDC shuttle vector containing the gene of interest
into AD-293 cells (Stratagene, La Jolla, CA) using FuGene 6
Transfection Reagent (Roche, Indianapolis, IN). AD-293 cell line
is a derivative of the commonly used HEK293 cell line, with
improved cell adherence and plaque formation properties. The
viruses were propagated in AD-293 cells and purified using CsCl2
banding, followed by dialysis against 20 mmol/L Tris-buffered
saline with 10% glycerol. Titering was performed on Ad293 cells
using Adeno-X Rapid Titer kit (Clontech) according to the
instructions of the manufacturer.
Figure 2. Association of Mst1 with GAPDH in cardiomyocytes.
A. Cell lysates obtained from NRVMs were immunoprecipitated with
anti-Mst1 antibody and then separated by 12% SDS-PAGE. Transferred
membrane was immunoblotted with either anti-GAPDH or Mst1
antibody. B, Tissue homogenates obtained from normal mouse heart
and hypertrophic heart were immunoprecipitated with anti-Mst1
antibody and then separated by 12% SDS-PAGE. Transferred membrane
was immunoblotted with either anti-GAPDH or Mst1 antibody.
doi:10.1371/journal.pone.0058697.g002
Functional Interaction of GAPDH with Mst1
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Induction of cardiac hypertrophy by chronic infusion of
isoproterenol (ISO)
C57BL/6 mice (20–25 g) were anesthetized with a mixture of
ketamine (50 mg/kg) and xylazine (2.5 mg/kg) intraperitoneally.
The mini-osmotic pumps (Alza corporation, Pa, Alto, CA) set to
dispense 0.5 ml/hr for 14 days were filled with PBS or ISO
(60 mg/kg/day) and pumps were implanted subcutaneously in the
back through a sub-scapular incision, which was then closed using
4.0 silk suture (Ethicon). Mice were followed by echocardiogram
prior to pump implantation and then weekly until the end of the 2
week period when mice developed cardiac hypertrophy. This
study was reviewed and approved by the Institutional Animal Care
and Use Committee at Thomas Jefferson University. Tissue
homogenates from normal heart and hypertrophied heart were
then subjected to immunoprecipitation by using anti-Mst1
antibody as previously described [25]
Detection of apoptosis
Histone-associated DNA fragments were quantitated by the Cell
Death Detection ELISA kit (Roche) [25]. Briefly, the cytoplasmic
fractions were added to the 96-well ELISA plates precoated with
the antihistone monoclonal antibody and incubated for 90 min at
room temperature. After washing, bound nucleosomes were
detected by the addition of anti–DNA-peroxidase monoclonal
antibody and reacted for 60 min at room temperature. After the
addition of substrate, absorbance was read with an ELISA reader
Figure 3. Identification of Mst1 and GAPDH interaction sites. A, schematic representation of Mst1 deletion mutants. B, flag-GAPDH
expression vector in combination of either empty vector or expression vectors of Myc-Mst1 mutants were cotransfected into HEK293T cells. Extracted
proteins were precipitated by anti-Myc antibody and then separated by 12% SDS-PAGE. The transferred membrane was immunoblotted with either
HRP-conjugated anti-FLAG or HRP-conjugated anti-Myc antibody. Lysates were also immunoblotted with anti-Flag antibody to show the expression
levels of Flag-GAPDH in HEK293T cells. C, schematic representation of GAPDH deletion mutants. D, Flag-Mst1 expression vector in combination of
either empty vector or expression vectors of Myc-GAPDH mutants were cotransfected into HEK293T cells. Extracted proteins were precipitated by
anti-Myc antibody and then separated by 12% SDS-PAGE. The transferred membrane was immunoblotted with either HRP-conjugated anti-FLAG or
HRP-conjugated anti-Myc antibody. Lysates were also immunoblotted with anti-Flag antibody to show the expression of Flag-Mst1 in HEK293 cells.
doi:10.1371/journal.pone.0058697.g003
Figure 4. Phosphorylation of GAPDH by Mst1. A, 0.1 mg active
Mst1 was incubated with different amounts of recombinant GAPDH for
60 min in the presence of 32P-ATP in an in vitro phosphorylation assay.
B, 0.1 mg active Mst1 was incubated with 4 mg bacterially expressed
recombinant GAPDH for different time points in the presence of 32P-
ATP in an in vitro phosphorylation assay. Phosphorylation was detected
by autoradiography. The data are representatives of 4 independent
experiments.
doi:10.1371/journal.pone.0058697.g004
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at 405 nm. Cardiomyocyte apoptosis measured by using Terminal
Transferase-mediated dUTP nick-end labeling (TUNEL) staining
was performed using the In Situ Cell Death Detection kit (Roche).
Statistical analyses
Data are expressed as means 6 SEM. The statistical
significance of differences was assessed by Student’s t tests or
ANOVA, as appropriate; a value of P,0.05 was considered
statistically significant.
Results
Interaction of GAPDH with Mst1
In an effort to identify novel Mst1 binding proteins, a yeast 2-
hybrid screening was performed with human dominant negative
Mst1 (DN-Mst1) as bait in conjunction with a human heart cDNA
library. After screening 2.46106 clones, we identified 4 positive
cDNAs encoding the C-terminal domain (aa 164–335) of
GAPDH, suggesting that the C-terminal region of GAPDH may
be sufficient to interact with Mst1 in yeast.
To determine whether the interaction between Mst1 and
GAPDH occurs in mammalian cells, coimmunoprecipitation
experiments were performed in HEK293T cells transfected with
GAPDH and Mst1 expression vectors. Immunoprecipitation of
FLAG-tagged GAPDH led to coimmunoprecipitation of Myc-
tagged Mst1 when both proteins were cotransfected (Figure 1A).
As a control, the anti-FLAG antibody did not immunoprecipitate
Myc-tagged Mst1 in the absence of FLAG-GAPDH. Similarly,
immunoprecipitation of Myc-tagged Mst1 resulted in coimmuno-
precipitation of FLAG-tagged GAPDH, whereas the anti-Myc
antibody did not immunoprecipitate FLAG-GAPDH in the
absence of Myc-Mst1 (Figure 1B). Interestingly, the interaction
of GAPDH with Mst1 was further increased by treatment of the
cells with the apoptotic agent etoposide (100 M) or TNF- (20 ng/
ml) for 6 hrs (Figure 1C). Together, these findings indicate that
GAPDH and Mst1 exist in the same complex in mammalian cells
both at baseline conditions and during apoptotic stress.
To determine whether there is an endogenous interaction of
GAPDH and Mst1 in cardiomyocytes, we performed immuno-
precipitation with anti-Mst1 antibody using lysates obtained from
neonatal rat ventricular cardiomyocytes (NRVMs). Indeed,
GAPDH was co-precipitated with the anti-Mst1 antibody but
not with the nonimmune IgG (Figure 2A). The interaction of
GAPDH and Mst1 was further examined in the heart. Similarly,
GAPDH was only co-immunoprecipitated with the anti-Mst1
antibody, but not with the nonimmune IgG in mouse heart
homogenates and this interaction was further increased in the
hypertrophic heart (Figure 2B). The results indicate that GAPDH
interacts with Mst1 in cardiomyocytes under physiological and
pathophysiological conditions.
Interaction domains of GAPDH and Mst1
To further map the interaction domains of GAPDH and Mst1,
we performed immunoprecipitation in HEK293 cells cotrans-
fected with different deletion mutants of Mst1 and GAPDH. We
first investigated the binding domains of GAPDH in Mst1. Mst1
contains an N-terminal kinase domain (aa 1–325), inhibitory
domain (aa 326–294), and a C-terminal dimerization domain (aa
395–487) [3] (Figure 3A). We generated a series of Mst1 deletion
mutants subcloned into pCS26MT vector with 66Myc tag and
transfected these mutants into HEK293 cells along with Flag-
GAPDH. Lysates from transfected HEK293T cells were immu-
noprecipitated with anti-myc antibody and analyzed by Western
blot analysis using anti-Flag and anti-Myc antibodies. We found
that Flag-GAPDH only bound to the N-terminal kinase domain of
Mst1 (figure 3B), suggesting that the kinase domain of Mst1 is
necessary for interaction with GAPDH.
GAPDH contains two functional domains, namely, the NAD
binding domain and the C-terminal catalytic domain [27]
(Figure 3C). To map the Mst1-binding domain in GAPDH,
Myc-tagged GAPDH mutants were cotransfected into HEK293T
cells with Flag-tagged Mst1. Lysates from transfected HEK293T
cells were immunoprecipitated with anti-Myc antibody and
analyzed by Western blotting analysis using anti-Flag and anti–
Myc-antibodies. As shown in Figure 3D, Mst1 interacted only with
the entire C-terminal catalytic domain of GAPDH, but not with
the NAD binding domain and the deletion mutants derived from
the C-terminal catalytic domain. Together, these results further
suggest that the C-terminal catalytic domain of GAPDH mediates
its interaction with Mst1.
Phosphorylation of GAPDH by Mst1
Since Mst1 is a serine/threonine kinase [1], the interaction of
Mst1 with GAPDH prompted us to investigate whether GAPDH
Figure 5. Activation of Mst1 kinase by GAPDH. A, 0.1 mg active
Mst1 was incubated with either 4 mg of recombinant GAPDH or MBP for
60 min in the presence of 32P-ATP in an in vitro phosphorylation assay.
Phosphorylation was detected by autoradiography. B, Mst1 immuno-
precipitated from HEK293 cells transfected with either Myc-Mst1 or
Myc-Mst1 plus Flag-GAPDH expression vectors was incubated with 2 mg
MBP for the in vitro kinase assay. Kinase assay was carried out in the
presence of 32P-ATP for 60 min. Phosphorylation was detected by
autoradiography. C, Phosphorylation levels of Mst1 and MBP were
quantified by densitometry of autoradiograms. Values are means 6
SEM obtained from 3 experiments.
doi:10.1371/journal.pone.0058697.g005
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is a substrate of Mst1. Therefore purified human GAPDH was
incubated with active recombinant Mst1 in the presence of
[c-32P]ATP in an in vitro phosphorylation assay. Indeed,
incubation of Mst1 with GAPDH induced a robust phosphory-
lation of GAPDH in a dose dependent manner (Figure 4A). To
determine the kinetics of Mst1-mediated phosphorylation of
GAPDH, the time course of Mst1 induced GAPDH phosphory-
lation was determined in vitro. Indeed, Mst1 phosphorylated
GAPDH in a time-dependent manner and reached saturation at
90 min (figure 4B). Strikingly, the activity of either recombinant or
endogenous GAPDH was not affected by either incubation with
recombinant Mst1 or transduction of cardiomyocytes with
adenovirus expressing Mst1 (data not shown).
Activation of Mst1 by GAPDH
To determine whether the interaction of GAPDH with Mst1
has functional consequences in terms of affecting Mst1 activity, we
performed an in vitro kinase assay by using either recombinant
Mst1 or Mst1 immunoprecipitated from HEK293 cells transfected
with the Myc-Mst1 cDNA together with empty vector or Flag-
GAPDH plasmid. As expected, incubation of recombinant Mst1
with its known substrate myelin basic protein (MBP) resulted in a
robust phosphorylation of MBP, which was not significantly
affected in the presence of GAPDH (Figure 5A). Moreover, the
phosphorylation activity of Mst1 on GAPDH was about the same
as that on the known substrate MBP (Figure 5A). Interestingly,
when Mst1 immunoprecipitated from HEK293T cells was used in
the kinase assay, cotransfection of GAPDH substantially increased
both the Mst1 autophosphorylation and Mst1 mediated MBP
phosphorylation by approximately 2-fold (Figure 5B and 5C).
These data suggest that other components present in the Mst1
immunocomplexes, but not in the recombinant Mst1, is required
for the activation of Mst1 by GAPDH.
Nuclear translocation of Mst1 and GAPDH during
cardiomyocyte apoptosis
GAPDH has been shown to induce cell apoptosis through its
nuclear translocation [28]. To determine whether GAPDH is
involved in cardiomyocyte apoptosis, neonatal rat cardiomyocytes
were treated with chelerythrine, a potent inducer of apoptosis [29].
Figure 6. Nuclear translocation of GAPDH and Mst1 during cardiomyocyte apoptosis. A, NRVMs were treated with chelerythrine (5 mM)
for different time points as indicated. Cytoplasmic and nuclear fractions were isolated and then subjected to western blot analysis using ant-GAPDH
and anti-histone H1A antibodies. The distribution of GAPDH in the cytoplasmic and nuclear fractions was analyzed by densitometric analysis. Values
are means 6 SEM obtained from 4 experiments. B, Unstimulated NRVMs or NRVMs stimulated with chelerythrine (5 mM) for 2 hours were fixed and
stained with anti-GAPDH monoclonal antibody and rabbit polyclonal anti-Mst1 antibody and processed for confocal imaging. The merged images
show clear colocalization of these 2 proteins in cytoplasm in ustimulated cells and translocation and colocalization of these 2 proteins in nucleus in
response to chelerythrine. C, NRVMs were transduced with either Ad-LacZ or Ad-Mst1 or Ad-DNMST (MOI = 30). 48 hr after transduction, cells were
treated with chelerythrine (5 mM) for 1 hour. Cytoplasmic and nuclear fractions were isolated and then subjected to western blot analysis using anti-
GAPDH and anti--tubulin antibodies. D, Unstimulated NRVMs or NRVMs stimulated with chelerythrine (5 mM) for 2 hours were lysed and then
subjected to immunoprecipitation with either normal IgG or anti-Mst1 antibody. Immunocomplexes were then separated by 15% SDS-PAGE and
transferred membrane was immunoblotted with either anti-GAPDH or Mst1 antibody.
doi:10.1371/journal.pone.0058697.g006
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The distribution of GAPDH between the cytoplamic and nuclear
fractions was then determined by western blotting analysis. As
shown in Figure 6A, in unstimulated cardiac cells, the majority of
GAPDH is located in the cytoplasm. However, treatment of
cardiomyocytes with chelerythrine for either 1 hr or 2 hr
substantially increased the amount of GAPDH in the nuclear
fraction. To further substantiate the role of Mst1 and GAPDH in
cardiomyocyte apoptosis, we performed immunofluorescence
staining to determine the intracellular localization of GAPDH
and Mst1 in cardiomyocytes. As shown in Figure 6B, the majority
of GAPDH and Mst1 is colocalized in the cytoplasm in
unstimulated cardiac cells. However, chelerythrine treatment led
to a marked translocation and co-localization of both GAPDH
and Mst1 in the nucleus. The kinase activity of Mst1 is not
required for the nuclear translocation of GAPDH, since
transduction of cardiomyocytes with adenovirus bearing either
wild-type Mst1 (Ad-Mst1, MOI= 30) or dominant negative Mst1
(Ad-DNMST, MOI= 30) had no effect on the nuclear transloca-
tion of GAPDH induced by chelerythrine stimulation (Figure 6C).
Furthermore, the interaction of GAPDH with Mst1 was further
increased in cardiomyocytes in response to chelerythrine treat-
ment, as demonstrated in the co-immunoprecipitation experiment
using anti-Mst1 antibody (Figure 6D). Together, these results
suggest that translocation of GAPDH and Mst1 into nucleus may
play an essential role in Mst1 activation and cardiomyocyte
apoptosis.
GAPDH enhances Mst1 induced cardiomyocyte
apoptosis
Because Mst1 has been characterized to induce cardiomyocyte
apoptosis [23,24], we investigated whether GAPDH can affect cell
apoptosis via its stimulatory effect on Mst1 in cardiac myocytes.
Indeed, transduction of cardiomyocytes with adenovirus bearing
GAPDH (Ad-GAPDH, MOI= 30) resulted in an increased
expression of GAPDH (Figure 7A). As expected, transduction of
cardiomyocytes with Ad-Mst1 (MOI= 30) significantly induced
apoptosis as compared with cells transduced with Ad-lacZ
(MOI= 30), as determined by the Cell Death ELISA (Roche)
(Figure 7B). However, transduction of cardiomyocytes with Ad-
GAPDH (MOI= 30) alone barely affected the basal levels of cell
apoptosis, but substantially enhanced the Mst1 induced apoptosis.
In addition, overexpression of GAPDH markedly augmented the
cardiomyocyte apoptosis in response to chelerythrine stimulation,
which was significantly inhibited by overexpression of DN-Mst1
(Figure 7C). These findings suggest that the interaction of GAPDH
with Mst1 may be functionally important in terms of regulating
Mst1-mediated cardiomyocyte apoptosis.
Figure 7. Overexpression of GAPDH enhances Mst1 mediated cardiomyocyte apoptosis. A, NRVMs were transduced with either Ad-LacZ
or Ad-GAPDH (MOI = 30). 48 hr after transduction, cell lysates were subjected to western blot analysis to detect the expression of GAPDH. B, NRVMs
were transduced with Ad-LacZ or Ad-GAPDH at 30 mois. Twenty-four hours after transduction, myocytes were transduced with Ad-LacZ or Ad-Mst1
at 30 mois. 48 hours after the second transduction, cytoplasmic accumulation of mono- and oligonucleosomes was quantitated by the Cell Death
Detection ELISA. Values are means 6 SEM obtained from 4 experiments. C, NRVMs were transduced with Ad-LacZ, Ad-GAPDH, or Ad-DNMST with
different combinations (total 60 mois). 48 hours after the transduction, the cells were treated with chelerythrine (5 mM) for 2 hours, the cytoplasmic
accumulation of mono- and oligonucleosomes was then quantitated by the Cell Death Detection ELISA. Values are means 6 SEM obtained from 4
experiments.
doi:10.1371/journal.pone.0058697.g007
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Knockdown of GAPDH attenuates Mst1 activation and
cardiomyocyte apoptosis
To further investigate the role of GAPDH in the regulation of
Mst1 mediated cardiomyocytes, we used siRNA to knockdown the
expression of GAPDH. Transfection of GAPDH siRNA (si-
GAPDH) reduced GAPDH expression by ,80% in cardiomyo-
cytes, as determined by both qRT-PCR (Figure 8A) and western
blot analysis (Figure 8B). Knockdown of GAPDH expression was
found to markedly attenuate Mst1 activity in response to
chelerythrine treatment, as compared with that in cells transfected
with control siRNA (siCTL) (Figure 8C). Moreover, knockdown of
GAPDH expression markedly inhibited the cardiomyocyte apop-
tosis in response to chelerythrine, as determined by TUNEL
staining (Figure 8D). However, transduction of cardiomyocytes
with Ad-Mst1 (MOI= 50) fully restored the cardiomyocyte
apoptosis induced by chelerythrine stimulation in cardiomyocytes
transfected with GAPDH siRNA (Figure 8D). Importantly,
knockdown of GAPDH also markedly inhibited hypoxia/reox-
ygenation induced Mst1 activation (Figure 9A) and cardiomyocyte
apoptosis (Figure 9B). Collectively, these findings further indicate
that GAPDH is a positive regulator of Mst1 activation in
cardiomyocyte apoptosis.
Discussion
Using the yeast 2-hybrid system and Mst1 as bait, we isolated
several GAPDH cDNAs from a human heart cDNA library. The
interaction of GAPDH with wild-type Mst1 was further supported
by coimmunoprecipitation studies showing that in both cotrans-
fected HEK293T cells and cardiomyocytes, GAPDH specifically
interacts with Mst1. The interaction between GAPDH and Mst1
requires the kinase domain of Mst1 and it seems that the C-
terminal catalytic domain of GAPDH mediates the binding of
Mst1 in GAPDH. Interestingly, GAPDH is phosphorylated by
Mst1 to a comparable extent as its known substrate MBP,
suggesting that GAPDH is a good substrate of Mst1 at least in
vitro. Furthermore, the functional consequence of this interaction
was demonstrated by the ability of GAPDH to enhance Mst1
activity and Mst1-mediated apoptotic effects in cardiomyocytes.
Indeed, inhibition of GAPDH expression attenuates the Mst1
activation and the Mst1 induced cardiomyocyte apoptosis in
Figure 8. Knockdown of GAPDH attenuates Mst1 activation and cell apoptosis in response to chelerythrine. A, Total RNA extracted
from control siRNA (siCTL) and GAPDH siRNA transfected cells was analyzed for the expression of GAPDH in NRCMs by qRT-PCR. B, NRVMs were
transfected with either control siRNA or GAPDH siRNA. 72 hours after transfection, cell lysates were then subjected to western blot analysis to detect
the expression of GAPDH. C, NRVMs were transfected with either control siRNA or GAPDH siRNA. 72 hours after transfection, cells were treated with
chelerythrine (5 mM) for 2 hours. Mst1 was then immunoprecipitated and its activity was determined by an in vitro kinase assay using histone H2B as
a substrate. D, NRVMs were transfected with either control siRNA or GAPDH siRNA. 24 hours after siRNA transfection, cells were then transduced with
either Ad-LacZ or Ad-Mst1 (MOI = 50). 48 hours after virus transduction, NRVMs were treated with chelerythrine (5 mM) for 2 hours and the cell
apoptosis was determined by using the TUNEL staining kit (Roche). Values are means 6 SEM obtained from 4 experiments.
doi:10.1371/journal.pone.0058697.g008
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response to chelerythrine. These results suggest that the regulation
of Mst1 activity by GAPDH may be an important determinant of
cell survival in the heart.
GAPDH is a key enzyme in the glycolytic pathway, which
catalyzes the conversion of glyceraldehyde-3-phosphate (G3P) to
1,3-biphosphoglycerate in the presence of NAD+ and inorganic
phosphate [28]. Recently, accumulating evidence suggests that in
addition to its canonical role in the glycolytic pathway, GAPDH
functions as a key component in the regulation of many
fundamental cellular functions [28]. Particularly, its roles in the
nucleus and in the regulation of cell apoptosis have attracted
significant attention [30,31]. Indeed, increased expression and
nuclear translocation of GAPDH has been implicated in the cell
apoptosis in several cell types [30,32,33]. However, at this time,
the molecular mechanism underlying the cell apoptosis triggered
by GAPDH nuclear translocation remains elusive. Recently,
nitrosative stress conditions have been shown to induce nitrosyla-
tion of GAPDH and its interaction with the ubiquitin ligase Siah1,
which translocates GAPDH to the nucleus [30]. In the nucleus,
GAPDH stabilizes the rapidly turning Siah1 complex, leading to
ubiquitination and subsequent degradation of selected target
proteins, thereby affecting apoptosis [30]. In addition, GAPDH
has been shown to facilitate apoptosis when localized to
mitochondria, where it induces the pro-apoptotic mitochondrial
membrane permeabilization and the release of pro-apoptotic
cytochome c [34]. The functional role of GAPDH in cardiomy-
ocyte apoptosis has begun to be explored. For instance, the
increased GAPDH gylcolytic activity induced by phenylephrine
treatment has recently been shown to protect the cardiomyocytes
from the starvation induced apoptosis [35] and this appears to
disagree with the conclusion of the present study. The cause of this
discrepancy may be due to the different external stimuli used for
inducing apoptosis, since increased GAPDH activity can generate
more ATP, which can counteract the decreased ATP levels during
the starvation induced apoptosis. Interestingly, a recent report
demonstrated that during nitric oxide (NO)-induced cardiomyo-
cyte apoptosis, GAPDH is translocated to the nucleus of
cardiomyocytes and overexpression of glutaredoxin protects
cardiomyocytes against NO induced apoptosis through suppress-
ing the translocation of GAPDH [36]. In the present study, our
data demonstrated that GAPDH specifically binds to Mst1 and
translocates to the nucleus during cardiomyocyte apoptosis.
Inhibition of GAPDH attenuates Mst1 activation and Mst1
mediated cardiomyocyte apoptosis. Thus, our findings identified
Mst1 as a novel downstream target of GAPDH in cardiomyocyte
apoptosis.
The Mst1 signaling pathway plays an essential role in cell
apoptosis [2]. Intact Mst1 is localized predominantly in the
cytoplasm, however, in response to a variety of apoptotic stimuli,
Mst1 is cleaved by caspases to produce the N-terminal constitu-
tively active kinase domain and this cleavage markedly increases
Mst1 kinase activity and translocates the cleaved Mst1 to the
nucleus [4–6]. In the present study, our results demonstrated that
both GAPDH and Mst1 translocated to the nucleus and strongly
colocalized in the nucleus in response to chelerythrine. The
interaction of GAPDH with Mst1 in the nucleus could be critical
for the execution of cell apoptosis, since GAPDH can further
augments Mst1 activity in the nucleus, thereby potentiating the
Mst1 induced apoptosis. In addition, the interaction of Mst1 with
GAPDH could further lead to GAPDH phosphorylation, therefore
affecting its interaction with other downstream targets such as
Siah1 and p300 in the nucleus [30,31], thereby influencing cell
apoptosis. Although the function of the Mst1 mediated GAPDH
phosphorylation remains unknown, it would be very interesting to
investigate whether Mst1 mediated GAPDH phosphorylation
affects its other functions in the nucleus, such as mediating RNA
nuclear export, gene transcription, mRNA stability, and telomere
protection [37,38].
The mechanism by which GAPDH activates Mst1 is not known,
but certainly involves other components in Mst1 immunocom-
plexes, as such an increased Mst1 activity by GAPDH was only
observed with immunoprecipitated Mst1 from HEK293 cells
transfected with Mst1 cDNA. Indeed, the Mst1 kinase signaling
cascade is tightly regulated by protein–protein interactions.
Several proteins, including Rassf1, hWW45 [17,19], PHLPP1
[20], and Death-associated Protein 4 (DAP4) [5], have been shown
to interact with Mst1, thereby influencing the activities of MST1/
2 kinases in mammalian cells. In this regard, it is attempting to
speculate that the interaction of GAPDH with Mst1 may cause a
conformational change of Mst1, thus affecting the formation of the
Mst1/Hippo signaling complex with other proteins, such as
Rassf1, hWW45, and Lats, which have recently been shown to
Figure 9. Knockdown of GAPDH attenuates Mst1 activation
and cell apoptosis in response to hypoxia/reoxygenation. A,
NRVMs were transfected with either control siRNA or GAPDH siRNA.
72 hours after transfection, cells were treated with hypoxia for 12 hours
and reoxygenation for 24 hours. Mst1 was then immunoprecipitated
and its activity was determined by an in vitro kinase assay using histone
H2B as a substrate. B, NRVMs were transfected with either control siRNA
or GAPDH siRNA. 72 hours after transfection, cells were treated with
hypoxia/reoxygenation and the cell apoptosis was determined by using
the TUNEL staining kit (Roche). Values are means 6 SEM obtained from
4 experiments.
doi:10.1371/journal.pone.0058697.g009
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play essential roles in the regulation of cardiomyocyte apoptosis
and heart failure [39,40]. These studies are ongoing.
In summary, we have found that GAPDH interacts with Mst1
kinase in cardiomyocytes. This interaction is specific and leads to a
functional increase in Mst1 activity and Mst1 mediated cardio-
myocyte apoptosis. These findings suggest that the GAPDH/Mst1
pathway may be an important therapeutic target for inhibiting
myocardial apoptosis in ischemia-reperfusion injury and heart
failure.
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